AI Article Synopsis
- The Drug Effectiveness Review Project (DERP) faces challenges in enhancing drug review processes for pharmacy and therapeutics (P&T) committees, despite its potential benefits.
- The need for timely and substantial evidence is a major obstacle for DERP and similar review systems, necessitating new methods for drug comparison.
- While a perfect review process is still not within reach, ongoing exploration of existing methodologies could lead to improvements in drug evaluation and effectiveness.
Article Abstract
The Drug Effectiveness Review Project (DERP) is a process with challenges as well as rewards. This Perspective explores the issues that hamper the DERP's effectiveness and discusses the changes it has generated in the drug review process for pharmacy and therapeutics (P&T) committees. The need for more timely and substantial evidence is a key barrier to all drug review processes; here I offer some alternative methods for comparing new drugs that have few comparators. A perfect process is a long way off. However, continuing to explore the methodologies in place today can lead us to more effective processes and metrics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1377/hlthaff.25.w276 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!